Liabilities of Anixa Biosciences Inc from 31 Oct 2013 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Anixa Biosciences Inc quarterly Liabilities in USD history and change rate from 31 Oct 2013 to 31 Oct 2025.
  • Anixa Biosciences Inc Liabilities for the quarter ending 31 Oct 2025 was $2,130,000, a 21% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,130,000 -$573,000 -21% 31 Oct 2025 10-K 12 Jan 2026 2025 FY
Q2 2025 $2,240,000 +$23,000 +1% 31 Jul 2025 10-Q 10 Sep 2025 2025 Q3
Q1 2025 $2,071,000 +$297,000 +17% 30 Apr 2025 10-Q 28 May 2025 2025 Q2
Q4 2024 $2,193,000 +$425,000 +24% 31 Jan 2025 10-Q 11 Mar 2025 2025 Q1
Q3 2024 $2,703,000 +$552,000 +26% 31 Oct 2024 10-K 12 Jan 2026 2025 FY
Q2 2024 $2,217,000 +$224,000 +11% 31 Jul 2024 10-Q 06 Sep 2024 2024 Q3
Q1 2024 $1,774,000 +$88,000 +5.2% 30 Apr 2024 10-Q 04 Jun 2024 2024 Q2
Q4 2023 $1,768,000 +$374,000 +27% 31 Jan 2024 10-Q 12 Mar 2024 2024 Q1
Q3 2023 $2,151,000 -$61,000 -2.8% 31 Oct 2023 10-K 10 Jan 2025 2024 FY
Q2 2023 $1,993,000 +$337,000 +20% 31 Jul 2023 10-Q 06 Sep 2023 2023 Q3
Q1 2023 $1,686,000 +$295,000 +21% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 $1,394,000 -$602,000 -30% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $2,212,000 +$722,000 +48% 31 Oct 2022 10-K 16 Jan 2024 2023 FY
Q2 2022 $1,656,000 31 Jul 2022 10-Q 09 Sep 2022 2022 Q3
Q1 2022 $1,391,000 30 Apr 2022 10-Q 10 Jun 2022 2022 Q2
Q4 2021 $1,996,000 31 Jan 2022 10-Q 11 Mar 2022 2022 Q1
Q3 2021 $1,490,000 +$301,409 +25% 31 Oct 2021 10-K 04 Jan 2023 2022 FY
Q3 2020 $1,188,591 -$292,724 -20% 31 Oct 2020 10-K 04 Jan 2022 2022 FY
Q2 2020 $1,223,774 31 Jul 2020 10-Q 08 Sep 2020 2020 Q3
Q1 2020 $1,102,645 30 Apr 2020 10-Q 09 Jun 2020 2020 Q2
Q4 2019 $1,166,351 31 Jan 2020 10-Q 09 Mar 2020 2020 Q1
Q3 2019 $1,481,315 31 Oct 2019 10-Q 08 Sep 2020 2020 Q3
Q3 2017 $889,493 -$3,751,139 -81% 31 Oct 2017 10-K 09 Jan 2018 2017 FY
Q2 2017 $2,926,688 -$1,676,361 -36% 31 Jul 2017 10-Q 08 Sep 2017 2017 Q3
Q1 2017 $3,660,023 -$985,975 -21% 30 Apr 2017 10-Q 26 May 2017 2017 Q2
Q4 2016 $8,037,122 +$2,981,027 +59% 31 Jan 2017 10-Q 16 Mar 2017 2017 Q1
Q3 2016 $4,640,632 +$358,663 +8.4% 31 Oct 2016 10-K 09 Jan 2018 2017 FY
Q2 2016 $4,603,049 +$321,323 +7.5% 31 Jul 2016 10-Q 19 Aug 2016 2016 Q3
Q1 2016 $4,645,998 +$503,243 +12% 30 Apr 2016 10-Q 20 May 2016 2016 Q2
Q4 2015 $5,056,095 +$43,275 +0.86% 31 Jan 2016 10-Q 19 Feb 2016 2016 Q1
Q3 2015 $4,281,969 -$763,814 -15% 31 Oct 2015 10-K 08 Dec 2016 2016 FY
Q2 2015 $4,281,726 -$8,967,900 -68% 31 Jul 2015 10-Q 18 Aug 2015 2015 Q3
Q1 2015 $4,142,755 30 Apr 2015 10-Q 22 May 2015 2015 Q2
Q4 2014 $5,012,820 31 Jan 2015 10-Q 09 Mar 2015 2015 Q1
Q3 2014 $5,045,783 -$3,714,348 -42% 31 Oct 2014 10-K 23 Dec 2015 2015 FY
Q2 2014 $13,249,626 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q3 2013 $8,760,131 31 Oct 2013 10-K 29 Jan 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.